Author

José Ferro

Université de Sherbrooke

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Andrew MitchelliD· 1 shared Christophe GonçalvesiD· 1 shared Daniel González‐MorenoiD· 1 shared Elizabeth M. GuettleriD· 1 shared Feiyang CaiiD· 1 shared Kelly CoutantiD· 1 shared Natascha GagnoniD· 1 shared Noah Wirasinghe· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrew MitchellORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

RAB1A is a novel vulnerability in uveal melanoma revealed by dual inhibition of MNK1/2 and mTOR.

Raúl Ernesto Flores González, Christophe Gonçalves, Noah Wirasinghe, Véronique Gaudreault, José Ferro, Kelly Coutant, Andrew Mitchell, Theodore Papadopoulos, Y. G. Cho, Elizabeth M. Guettler, Daniel González‐Moreno, Samuel E.J. Preston, Feiyang Cai, Natascha Gagnon, Steve Jean, , Sonia Victoria Del Rincon

This study identifies RAB1A as a vulnerability in uveal melanoma through dual inhibition of MNK1/2 and mTOR, showing it disrupts protein trafficking and blocks liver metastasis.

Cell Death and Differentiation · Feb 18, 2026Peer-reviewedCancer Biology